Psychoactive drugs in the immature organism.
D000661:Amphetamine / Q000627:therapeutic use; D000818:Animals; D001321:Autistic Disorder / Q000188:drug therapy; D001522:Behavior, Animal / Q000187:drug effects; D002395:Catecholamines / Q000494:pharmacology; D002648:Child; D002652:Child Behavior / Q000187:drug effects*; D002653:Child Behavior Disorders / Q000188:drug therapy; D002675:Child, Preschool; D002746:Chlorpromazine / Q000494:pharmacology; D002986:Clinical Trials as Topic; D003913:Dextroamphetamine / Q000627:therapeutic use; D005260:Female; D003932:Heroin / Q000633:toxicity; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D007858:Learning / Q000187:drug effects; D008099:Liver / Q000201:enzymology; D008431:Maternal-Fetal Exchange; D010640:Phenothiazines / Q000627:therapeutic use; D010919:Placebos; D011247:Pregnancy; D011248:Pregnancy Complications; D011600:Psychopharmacology; D012154:Reticular Formation / Q000503:physiopathology; D012561:Schizophrenia, Childhood / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome
D002395:Catecholamines; D010640:Phenothiazines; D010919:Placebos; D003932:Heroin; D000661:Amphetamine; D003913:Dextroamphetamine; D002746:Chlorpromazine